Psychopharmacology research for individuals with mental retardation: methodological issues and suggestions

Psychotropic medications are frequently prescribed for behavior problems and/or psychopathology among individuals with mental retardation (MR). Unfortunately, the methodological integrity of scientific studies that support the use of medications among this population is often lacking. A recent revie...

Full description

Saved in:
Bibliographic Details
Published in:Research in developmental disabilities 2003-05, Vol.24 (3), p.149-157
Main Authors: Matson, Johnny L., Bielecki, JoAnne, Mayville, Stephen B., Matson, Michael L.
Format: Article
Language:English
Subjects:
Adults
behavioral assessment
Biological and medical sciences
Clinical Trials as Topic
Drug Therapy
Elementary Secondary Education
Guidelines
Humans
Intellectual Disability - complications
Intellectual Disability - drug therapy
Intellectual Disability - psychology
Medical sciences
Mental Disorders - drug therapy
Mental Disorders - etiology
Mental Retardation
Methodology. Experimentation
Program Effectiveness
Program Evaluation
Psychology. Psychoanalysis. Psychiatry
Psychopathology. Psychiatry
Psychopharmacology - standards
Psychopharmacology - trends
psychopharmacology research
Psychotropic Drugs - pharmacology
Psychotropic Drugs - therapeutic use
Quality Control
Research Design
Research Methodology
Research Needs
Research Problems
Techniques and methods
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Psychotropic medications are frequently prescribed for behavior problems and/or psychopathology among individuals with mental retardation (MR). Unfortunately, the methodological integrity of scientific studies that support the use of medications among this population is often lacking. A recent review of the literature revealed that many of the studies that have assessed the efficacy of psychotropic medications for individuals with MR are methodologically flawed. Thus, we have detailed suggestions to improve the quality of future medication studies and avoid the methodological problems that prevent the scientific advancement of psychopharmacological research among individuals with MR.
ISSN:0891-4222
1873-3379
DOI:10.1016/S0891-4222(03)00030-1